Clinicopathological Features, Treatment, and Outcome of Omani Patients with Metastatic Prostate Cancer
Objectives: Prostate cancer (PCa) is the third most common cancer worldwide, with its incidence rising in the Middle East. There is a paucity of data about the clinicopathological features and outcomes of metastatic prostate cancer (mPCa) from the Middle East. We report the outcomes of mPCa from Oma...
Main Authors: | Shiyam Kumar, Ikram A. Burney, Joseph Kunju, Mohammed Salim Al-Marhoon, Khurrum Mutahir Siddiqui |
---|---|
Format: | Article |
Language: | English |
Published: |
Oman Medical Specialty Board
2022-01-01
|
Series: | Oman Medical Journal |
Subjects: | |
Online Access: | https://omjournal.org/articleDetails.aspx?coType=1&aId=3053 |
Similar Items
-
Impact of clinical trial participation on survival in patients with castration-resistant prostate cancer: a multi-center analysis
by: Kyo Chul Koo, et al.
Published: (2018-04-01) -
Enhancing androgen ablation response in metastatic
hormone-sensitive prostate cancer: the benefits of
transurethral resection of the prostate
by: Yan Zhao, et al.
Published: (2023-07-01) -
Microvascular invasion is an independent prognostic factor in patients with prostate cancer treated with radical prostatectomy
by: Alberto A. Antunes, et al.
Published: (2006-12-01) -
Impact of local treatment on overall survival of patients with metastatic prostate cancer: systematic review and meta-analysis
by: Arie Carneiro, et al. -
Efficacy and safety of Prostate stereotactic body radiotherapy for metastatic castration-resistant prostate cancer: A prospective cohort study
by: Jun Li, et al.
Published: (2021-01-01)